RG

Ritika Gahlot

Director Director DIN 09376292
DIN 09376292 First appointment Oct 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Ritika Gahlot

Ritika Gahlot has 4 years in corporate governance. Formerly with 1 company, such as Medone Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09376292
Primary Designation Director
First Appointment 26 Oct 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Medone Pharma Private Limited U51909DL2021PTC388980
Director 26 Oct 2021 2021 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medone Pharma Private Limited
Premium access

Shareholding and investment profile for Ritika Gahlot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritika Gahlot

Ritika Gahlot has 4 years in corporate governance. Formerly with 1 company, such as Medone Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ritika Gahlot is associated with 0 companies as a director.

Ritika Gahlot has expertise in General Business.

Ritika Gahlot has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available